Out-Licensing
Out-Licensing
Novel therapeutic approaches, diagnostic and prognostic markers, and R&D tools discovered and developed at our center are made available for collaborators that wish to be involved in making them available to Society.
- Biomarker for Non-invasive Colorectal Cancer Screening
Colorectal cancer (CRC) is the third most common malignant neoplasm worldwide in men (746,000 cases, 10.0% of the total) and the second in women (614,000 cases, 9.2% of the total) worldwide. CRC incidence declined by 3% per year among adults aged 50 years and older. Screening tests like sigmoidos... - High Affinity Sumo Traps
Small Ubiquitin-like Modifier (or SUMO) proteins are covalently attached to other proteins in cells to modify their function, also called SUMOylation. This is mediated by a multistep enzymatic cascade, similar to ubiquitination. SUMOylation is a dynamic process that can change the subcellular loc... - In vitro Fertilization sucess rate prediction method
In vitro fertilization (IVF) refers to procedures that assist with the fertilization of an embryo. IVF involves the collection of eggs from the ovaries and subsequent fertilization by sperm, and is carried out in a laboratory setting. Once the process is complete, the fertilized egg is transplant... - Methods for prognosis of prostate cancer
Almost 1 million prostate cancer patients are diagnosed every year worldwide, being the 6th leading cause of cancer death in males. Prostate specific antigen (PSA) is the only routinely implemented clinical biomarker for prostate cancer detection that together with the so called Gleason Score (wh... - Ubiquitin-binding polypeptides
Ubiquitin is a small protein with regulatory function found in most tissues. It can be covalently attached to substrate proteins (known as ubiquitination) and affects their function in different ways: 1) alter cellular location, 2) affect activity, 3) prevent interaction with other proteins or mo...